Head Chair of Systems & Synthetic Biology
SEEK ID: https://ibisbahub.eu/people/66
Joined: 6th Jun 2019
This person has not yet tagged anything.
IBISBA is designed to accelerate end-to-end bioprocess development, linking best-in-class R&D facilities to provide seamless multi-technology services.
Focusing on the different R&D phases in bioprocess development, IBISBA offers services related to computer-assisted design of biocomponents, construction of enzymes and microbial strains, the fermentation, downstream processing and project knowledge asset management.
Web page: http://www.ibisba.eu
IBISBA offers access to best-in-class facilities and know-how. Clients from academia, SMEs and big industry can find tailored solutions for their R&D needs.
Using a H2020 funding framework, IBISBA currently offers limited opportunities to researchers to obtain subsidised access to IBISBA specialised research structures and facilities, including contribution to user's travel and subsistence costs. Open Calls are launched regularly, inviting researchers from all sectors (academia and industry) ...
Projects: TRANSCRIPTPROM - Integrative and comparative analyses of response of Pichia pastoris, FLOX: FLavin-containing OXidoreductases, PlanOvac, HIGHFLUX, SporeDel, Yeast Glycerol, Galambr, SULFOCEL, Muconic Acid Production, Promoters 4 Pichia, Evocolour - The evolution and genetics of Flavobacteria forming structurally coloured colonies for sustainable biomaterials, Extreme - Genomic approach for extremozymes screening of thermophilic/anaerobic Caldicoprobacter algerensis strain, HMOzyme, PILOT-MP - Pilot scale process development for microbial proteins, UMB - Upscaling and optimisation of microalgae production for bivalves hatchery, Biocare, MEOX, Coculture, YarroFuels, PlasticPutida, Lipro-alga, Cyanofcs, ENGINEER4ARGININE, Upscale of the biocatalytic transformation of Free Fatty Acids into high-value products (BIOFFA), B-PAC, BIOFFA, GLYCOMICS, KorallionBio, MAROX, PROTEIFROM, SUPI
This first IBISBA policy brief provides an overview of state of play in industrial biotechnology and underlines the need for further investment in Europe.
This policy note is the second one produced by IBISBA. It briefly describes international developments in the field of industrial biotechnology and alerts on the fact that Europe risks to lose its competitive edge.